Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Alternative splicing (AS) is one of the principal mechanisms of post‑transcriptional regulation that confers transcriptomic plasticity and proteomic diversity in cancer, thereby enabling tumor adaptation to therapeutic pressure. However, two obstacles impede the translation of these findings into clinical benefit: The absence of systematic functional annotation of the numerous splice variants asso...
Acute myeloid leukaemia (AML) is an aggressive haematological malignancy with an incidence that increases with age and varies widely across regions owing to differences in risk factors, diagnostic capabilities, recording in cancer registries and access to health care. Despite improved outcomes over the past decade owing to the approvals of various novel therapies as well as improvements in support...
The human microbiome, encompassing microbial communities in the gut and breast tissue, has emerged as a critical modulator of breast cancer (BC) initi...
OBJECTIVES: Electromyography (EMG) is increasingly applied in oncology to monitor neuromuscular impairment, treatment toxicities, and rehabilitation o...
OBJECTIVES: Pain-fatigue-sleep disturbance symptom (PFS) cluster is the most common symptom cluster in patients with lung cancer following chemotherap...
BACKGROUND: Lactylation is acknowledged as a regulator of numerous biological processes related to cancer. Research on the ability of lactylation-rela...
BACKGROUND AND OBJECTIVE: Early detection of oral cavity cancers is critical for improving patient survival rates and treatment efficacy. In this cont...
BACKGROUND: Liquid biopsy, combined with multi-omics profiling and artificial intelligence (AI), offers a minimally invasive strategy for cancer detec...
BACKGROUND: Our descriptive study focused on morphologic characteristics of hyperchromatic crowded groups (HCGs) in ThinPrep cervical cytology tests w...
OBJECTIVE: This systematic literature review explores how temporal and time-related dimensions are incorporated into Machine Learning (ML) models used...
DNA methylation-based classification is now central to contemporary neuro-oncology, as highlighted by the World Health Organization (WHO) classificati...
We report the results of LINUX (NCT05594095), a multicenter, randomized, controlled phase II platform trial aiming to identify effective precision tre...
BACKGROUND: Curative-intent radiotherapy (RT) or chemoradiotherapy (CRT) for head and neck squamous cell carcinoma (HNSCC) frequently leads to mucosit...
Emerging evidence highlights RNA N6-methyladenosine (m6A) modifications as pivotal regulators of tumorigenesis, yet the synergistic roles of m6A reade...
BACKGROUND: Predicting clinical and radiological outcomes of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in patients with ...
BACKGROUND: Accurate pathological classification of lung cancer is essential for informing treatment strategies. However, invasive biopsy procedures a...
Leukemia is a significant clinical issue, and some of its subtypes are characterized by dysregulated prenylation-dependent signaling that contributes ...
Ebracteolatain A (EA), a potential anti-cancer agent, has demonstrated efficacy against breast cancer through protein kinase D1 inhibition. However, i...
Early detection of hepatocellular carcinoma (HCC) remains a critical challenge due to the disease's complexity and the limitations of current screenin...
The effective treatment of bladder cancer depends on early evaluation through cystoscopy. Given the clinical importance of distinguishing the tumor gr...